# Simultaneous Diagnosis of Myasthenia Gravis and Neurosyphilis, With Symptoms Improving After Neurosyphilis Treatment: A Case Report

**Authors:** Juan Fernando Ortiz, Nicholas J Lannen, Maria Daniela Peralta, Camila D Lopez

PMC · DOI: 10.7759/cureus.102139 · 2026-01-23

## TL;DR

A rare case where a patient had both myasthenia gravis and neurosyphilis, with symptoms improving after treating the neurosyphilis.

## Contribution

This is the first reported case of myasthenia gravis resolving after neurosyphilis treatment.

## Key findings

- The patient's neurological symptoms resolved after neurosyphilis treatment.
- The patient was later diagnosed with myasthenia gravis via acetylcholine receptor antibodies and EMG.
- Neurosyphilis may trigger autoimmune conditions like myasthenia gravis.

## Abstract

Simultaneous diagnosis of myasthenia gravis (MG) and early asymptomatic neurosyphilis is extremely rare. There have only been two cases described in the literature. To the best of our knowledge, this was the first case of MG resolving with concurrent treatment of neurosyphilis.

Our patient was a 67-year-old male who presented to the hospital with a diffuse rash, bilateral ptosis, bilateral facial weakness, and bulbar symptoms (dysarthria, difficulty with mastication, and difficulty drinking fluids).  After testing positive for syphilis in serum and cerebrospinal fluid (CSF), the patient was diagnosed with neurosyphilis. Thus, it was suspected that his neurological findings were manifestations of early symptomatic neurosyphilis. The patient was treated with intravenous penicillin G for one week, and later, it was switched to intravenous ceftriaxone for two weeks due to cost and convenience. All symptoms resolved after three to four weeks. After being discharged, the patient tested positive for acetylcholine receptor antibodies. Subsequently, the patient underwent an electromyogram (EMG), which revealed a decremental response, confirming a diagnosis of MG. Infections are known to trigger autoimmune diseases and can lead to the development of new-onset MG.

Neurosyphilis is relatively highly associated with other central nervous system (CNS) antibodies and can trigger other neurological disorders. Recognizing the differences in presentation and performing an accurate and comprehensive neurological exam can help differentiate early symptomatic neurosyphilis from neuromuscular disorders such as MG.

## Linked entities

- **Chemicals:** penicillin G (PubChem CID 5904), ceftriaxone (PubChem CID 5479530)
- **Diseases:** myasthenia gravis (MONDO:0009688), neurosyphilis (MONDO:0004944), syphilis (MONDO:0005976)

## Full-text entities

- **Genes:** GAD2 (glutamate decarboxylase 2) [NCBI Gene 2572] {aka GAD65}, MUSK (muscle associated receptor tyrosine kinase) [NCBI Gene 4593] {aka CMS9, FADS}, AQP4 (aquaporin 4) [NCBI Gene 361] {aka MIWC, MLC4, WCH4, hAQP4}, LRP4 (LDL receptor related protein 4) [NCBI Gene 4038] {aka CLSS, CMS17, LRP-4, LRP10, MEGF7, SOST2}
- **Diseases:** Syphilis (MESH:D013587), myasthenia (MESH:D020294), inflammation (MESH:D007249), immune impairment (MESH:D020274), Neurosyphilis (MESH:D009494), facial weakness (MESH:D018908), anti-N-methyl-D-aspartate (NMDA) receptor encephalitis (MESH:D060426), GBS (MESH:D020275), Venereal Disease (MESH:D012749), meningovascular disease (MESH:D013606), meningitis (MESH:D008580), hepatitis B (MESH:D006509), hepatitis C (MESH:D019698), Heubner arteritis (MESH:D001167), autoimmune conditions (MESH:D001327), Erythematous rash (MESH:D005076), stroke (MESH:D020521), fatigue (MESH:D005221), dysarthria (MESH:D004401), respiratory distress (MESH:D012128), cranial nerve palsies (specifically III, VI, VII, VIII (MESH:D020434), neurological disorders (MESH:D009461), impaired neuromuscular transmission (MESH:D020511), difficulty with mastication (MESH:D051346), Nissl-Alzheimer arteritis (MESH:D012183), bulbar (MESH:D010244), dysphagia (MESH:D003680), Stiff Person Syndrome (MESH:D016750), hypertension (MESH:D006973), axonal or demyelinating damage (MESH:D003711), diplopia (MESH:D004172), encephalitis (MESH:D004660), Infections (MESH:D007239), CSF pleocytosis (MESH:D007964), aphasia (MESH:D001037), Ptosis (MESH:C564553), type 2 diabetes (MESH:D003924), syphilitic meningitis (MESH:C536775), autoimmune disruption of acetylcholine receptors (MESH:C536090), thymoma (MESH:D013945), neuromuscular disorders (MESH:D009468), sleep apnea (MESH:D012891), NMOSD (MESH:D009471), hydrocephalus (MESH:D006849), MG (MESH:D009157), Infectious diseases (MESH:D003141)
- **Chemicals:** ACh (MESH:D000109), penicillin G (MESH:D010400), penicillin (MESH:D010406), ceftriaxone (MESH:D002443)
- **Species:** Zika virus (no rank) [taxon 64320], Human immunodeficiency virus 1 (no rank) [taxon 11676], Homo sapiens (human, species) [taxon 9606], Treponema pallidum (species) [taxon 160], West Nile virus (no rank) [taxon 11082]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12925367/full.md

---
Source: https://tomesphere.com/paper/PMC12925367